Advent sells Romanian pharma for $324m

India’s Ranbaxy Laboratories, unsuccessful in its bid for 3i’s German pharma business betapharm in February, has paid $324m for Advent International-backed Terapia.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this